Profile | GDS4284 / 212445_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 164.608 | 46 |
GSM687648 | Patient 402 control | 387.219 | 60 |
GSM687653 | Patient 403 control | 173.212 | 47 |
GSM687658 | Patient 404 control | 199.281 | 48 |
GSM687663 | Patient 411 control | 255.651 | 52 |
GSM687668 | Patient 422 control | 190.031 | 48 |
GSM687673 | Patient 424 control | 513.694 | 63 |
GSM687678 | Patient 425 control | 387.663 | 59 |
GSM687683 | Patient 427 control | 265.454 | 52 |
GSM687688 | Patient 428 control | 161.527 | 44 |
GSM687695 | Patient 441 control | 1562.14 | 82 |
GSM687699 | Patient 443 control | 168.489 | 41 |
GSM687704 | Patient 444 control | 324.274 | 57 |
GSM687707 | Patient 448 control | 244.089 | 49 |
GSM687712 | Patient 449 control | 300.656 | 55 |
GSM687719 | Patient 450 control | 316.086 | 54 |
GSM687724 | Patient 451 control | 373.113 | 59 |
GSM687728 | Patient 452 control | 288.252 | 54 |
GSM687646 | Patient 401 treated 24h | 138.158 | 41 |
GSM687649 | Patient 402 treated 24h | 322.319 | 57 |
GSM687665 | Patient 411 treated 24h | 150.109 | 40 |
GSM687651 | Patient 402 treated 4 weeks | 350.599 | 57 |
GSM687667 | Patient 411 treated 4 weeks | 121.83 | 38 |
GSM687670 | Patient 422 treated 24h | 197.239 | 47 |
GSM687671 | Patient 422 treated 4 weeks | 126.634 | 40 |
GSM687654 | Patient 403 treated 24h | 79.1841 | 32 |
GSM687675 | Patient 424 treated 24h | 618.931 | 66 |
GSM687685 | Patient 427 treated 24h | 240.114 | 51 |
GSM687656 | Patient 403 treated 4 weeks | 83.8135 | 34 |
GSM687677 | Patient 424 treated 4 weeks | 332.489 | 57 |
GSM687687 | Patient 427 treated 4 weeks | 122.071 | 41 |
GSM687692 | Patient 428 treated 4h | 257.499 | 53 |
GSM687716 | Patient 449 treated 4h | 234.18 | 52 |
GSM687722 | Patient 450 treated 4h | 283.573 | 52 |
GSM687680 | Patient 425 treated 24h | 275.396 | 54 |
GSM687690 | Patient 428 treated 24h | 227.451 | 52 |
GSM687700 | Patient 443 treated 24h | 689.025 | 67 |
GSM687705 | Patient 444 treated 24h | 255.655 | 54 |
GSM687714 | Patient 449 treated 24h | 198.435 | 50 |
GSM687721 | Patient 450 treated 24h | 749.695 | 69 |
GSM687682 | Patient 425 treated 4 weeks | 285.746 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 272.723 | 55 |
GSM687702 | Patient 443 treated 4 weeks | 295.974 | 53 |
GSM687718 | Patient 449 treated 4 weeks | 79.8001 | 29 |
GSM687723 | Patient 450 treated 4 weeks | 334.916 | 57 |
GSM687661 | Patient 404 treated 4h | 285.531 | 54 |
GSM687710 | Patient 448 treated 4h | 338.898 | 58 |
GSM687726 | Patient 451 treated 4h | 495.469 | 63 |
GSM687730 | Patient 452 treated 4h | 613.658 | 62 |
GSM687660 | Patient 404 treated 24h | 484.178 | 63 |
GSM687697 | Patient 441 treated 24h | 799.925 | 71 |
GSM687709 | Patient 448 treated 24h | 263.994 | 52 |
GSM687725 | Patient 451 treated 24h | 574.756 | 65 |
GSM687729 | Patient 452 treated 24h | 936.653 | 75 |
GSM687727 | Patient 451 treated 4 weeks | 351.065 | 57 |
GSM687731 | Patient 452 treated 4 weeks | 320.665 | 55 |